Day: May 26, 2021

Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced it will be rescheduling the company’s 2021 Annual Meeting of Shareholders (the “2021 Annual Meeting”), which was previously scheduled for July 16, 2021. Once determined by the Scopus Board of Directors, the company will announce the new date, time and location of the 2021 Annual Meeting. About Scopus BioPharma Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company’s lead drug candidate is a novel, targeted immuno-oncology RNA therapy for the treatment of multiple cancers. This drug candidate is highly distinctive, encompassing both RNA therapy and immunotherapy by synthetically...

Continue reading

Rise Capital Corp. Completes Initial Public Offering; Common Shares Will Commence Trading on the TSX Venture Exchange

Rise Capital Corp. Completes Initial Public Offering; Common Shares Will Commence Trading on the TSX Venture Exchange

TORONTO, May 26, 2021 (GLOBE NEWSWIRE) — Rise Capital Corp. (TSXV: RSE) (the “Corporation“) is pleased to announce that it has successfully completed its initial public offering of 45,000,000 common shares (the “Common Shares“) at $0.20 per share for gross proceeds of $9,000,000 (the “Offering“). As a result of this issuance, the Corporation has 55,000,000 Common Shares issued and outstanding of which 10,000,000 Common Shares are subject to escrow restrictions as disclosed in the Corporation’s final prospectus dated May 6, 2021, a copy of which may be obtained at www.sedar.com. Hampton Securities Limited (the “Agent“) acted as agent for the Offering. In connection with the Offering, the Agent received a cash commission of $419,328.00, representing 6% of the gross proceeds of...

Continue reading

Titanium Corporation Reports Results for the First Quarter Ended March 31, 2021 and Provides Project Update

Titanium Corporation Reports Results for the First Quarter Ended March 31, 2021 and Provides Project Update

CALGARY, Alberta, May 26, 2021 (GLOBE NEWSWIRE) — Titanium Corporation Inc. (the “Company” or “Titanium”) (TSX-V: TIC) today released its results for the three months ended March 31, 2021. During the first quarter of 2021, the joint project team for the Company and Canadian Natural Resources Limited (“Canadian Natural”) continued work towards the implementation of Titanium’s Creating Value from Waste™ (“CVW™”) technology at Canadian Natural’s Horizon oil sands site (the “Project” or the “CVW™ Horizon Project”). The Project work included finalizing engineering reviews of the concentrator facility, engineering redesign of the minerals and transload facilities and updating engineering cost estimates. The results of the engineering work are currently under review, including Project cost estimates, economic analysis and environmental...

Continue reading

GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients

GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients

– Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or death in high-risk adult outpatients compared to placebo, based on interim results from Phase 3 COMET-ICE trial – – In vitro data indicate sotrovimab maintains activity against all known variants of concern, including the variant from India – – Sotrovimab will be available for appropriate patients diagnosed with COVID-19 in the U.S. in the coming weeks – – Discussions with global regulators regarding authorizations in additional countries continue to advance – LONDON and SAN FRANCISCO, May 26, 2021 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for sotrovimab (previously VIR-7831), an investigational...

Continue reading

MJardin Group, Inc. Announces two new Board Members

MJardin Group, Inc. Announces two new Board Members

DENVER and TORONTO, May 26, 2021 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or the “Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced that Blair Jordan and Anthony Dutton are joining the Board of Directors, effective May 26, 2021, filling the two vacant positions. MJardin expects the following independent board members to strengthen its Board with refreshed perspectives and diverse expertise in executive advisory, strategic planning, restructuring, marketing, corporate development, and finance: Blair Jordan is currently the managing partner of Restructur Advisors, a turnaround and restructuring consulting firm focused on Canada, with particular expertise in the cannabis and cannabinoid sector. Blair has acted as a turnaround consultant for several cannabis companies, including...

Continue reading

Imperial Announces Voting Results for the Election of Directors

Imperial Announces Voting Results for the Election of Directors

VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management information circular dated April 1, 2021 were elected as directors of the Company at the Annual General Meeting of Shareholders (the “Meeting”). Results of the vote for the election of directors held at the Meeting on May 26, 2021 in Vancouver, British Columbia are: Nominee   Votes For %   Votes Withheld % J. Brian Kynoch   80,544,526 99.98   12,113 0.02 Pierre Lebel   76,982,936 95.56   3,573,703 4.44 Larry G. Moeller   80,483,193 99.91   73,446 0.09 Theodore W. Muraro   80,459,671 99.88   96,968 0.12 Janine North   80,553,036 100.00   3,603 0.00 James P. Veitch   80,491,478 99.92   65,161 0.08 Edward...

Continue reading

Lightbridge Corporation Announces Postponement of Annual Meeting of Shareholders

Lightbridge Corporation Announces Postponement of Annual Meeting of Shareholders

RESTON, Va., May 26, 2021 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it is postponing its Annual Meeting of Stockholders (the “Meeting”) to Monday, June 28, 2021 at 11am ET to provide its shareholders with additional time to vote on the proposals submitted for shareholder approval at the Meeting. Shareholders are advised that because one of the proposals involves proposed amendments to the Company’s Articles of Incorporation, the holders of a majority of the outstanding shares of Lightbridge common stock must approve such proposal. The record date for determining the shareholders eligible to vote at the Meeting will remain the close of business on March 29, 2021. Shareholders who have already submitted a proxy do not need to vote again for the postponed...

Continue reading

Dividend Growth Split Corp. Announces Successful Overnight Offering

Dividend Growth Split Corp. Announces Successful Overnight Offering

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, May 26, 2021 (GLOBE NEWSWIRE) — (TSX: DGS, DGS.PR.A) Dividend Growth Split Corp. (the “Company”) is pleased to announce a successful overnight treasury offering of class A shares and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively). Gross proceeds of the offering are expected to be approximately $34.8 million. The offering is expected to close on or about June 1, 2021 and is subject to certain closing conditions. The Company has granted the Agents (as defined below) an over-allotment option, exercisable for 30 days following the closing date of the offering, to purchase up to an additional 15% of the number of Class A Shares and Preferred Shares issued at the closing of the offering. The Class A Shares...

Continue reading

Safe Bulkers, Inc. Announces Upsizing of At-the-Market (ATM) Program

Safe Bulkers, Inc. Announces Upsizing of At-the-Market (ATM) Program

MONACO, May 26, 2021 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (NYSE: SB) (the “Company”), an international provider of marine drybulk transportation services, increased to $100.0 million the maximum aggregate dollar amount of shares of the Company’s common stock that may be sold under its previously announced at-the-market (“ATM”) program established on August 7, 2020 with DNB Markets. Inc. (“DNB”), as sales agent. On May 26, 2021, the Company filed a prospectus supplement in connection with an amendment to its previously disclosed Sales Agreement with DNB to increase the size of its at-the-market program pursuant to which the Company may now offer and sell, from time to time through DNB, shares of the Company’s common stock having an aggregate offering price up to $100.0 million. As of May 25, 2021, the Company has sold approximately...

Continue reading

Wesdome Announces Positive Pre-Feasibility Study and Restart Decision for the Kiena Mine in Val d’Or, Quebec; IRR of 98%

Wesdome Announces Positive Pre-Feasibility Study and Restart Decision for the Kiena Mine in Val d’Or, Quebec; IRR of 98%

Figure 1 Gold Production by Year TORONTO, May 26, 2021 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX:WDO) (“Wesdome” or the “Company”) is pleased to announce positive results from the independent Pre-Feasibility Study (“PFS”) prepared in accordance with the requirements of National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) at its 100% owned Kiena Complex in Val d’Or, Quebec. Based on the results of the PFS, the Board of Directors of the Company has made a restart decision for the Kiena Complex, commencing immediately. Highlights of the PFS are outlined below. All figures are in Canadian dollars unless otherwise stated: After-tax NPV5% of $367 million at US$1,600 per ounce gold, increasing to an after-tax NPV5% of $491 million at US$1,900 per ounce gold using CAD/USD exchange...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.